Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02241525 · ClinicalTrials.gov registry record
CT for Pulmonary Thromboembolic Disease
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02241525 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants.
The verdict
NCT02241525 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography (CTPA) for the diagnosis of pulmonary thromboembolic disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02241525
The ClinicalTrials.gov registry entry for NCT02241525 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02241525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02241525 about?
NCT02241525 is a clinical study titled "CT for Pulmonary Thromboembolic Disease". Examine the feasibility and efficacy of individually optimized uniform contrast enhancement in CT pulmonary angiography (CTPA) for the diagnosis of pulmonary thromboembolic disease.
What is the current status of trial NCT02241525?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-02. Estimated completion is 2016-05.
Who is sponsoring clinical trial NCT02241525?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.